CentroDerm GmbH

At CentroDerm GmbH the dermatology department conducts research on immune system diseases, with a focus on seasonal allergies. One trial evaluates a subcutaneous allergoid for birch pollen‑induced allergic rhinitis and rhinoconjunctivitis, measuring symptom reduction and medication need during the peak pollen season.

• Allergen immunotherapy efficacy
• Subcutaneous administration strategies
• Seasonal symptom tracking
• Placebo‑controlled study design
• Patient‑reported outcome measures

Based in Wuppertal, Germany, the site manages 7 active trials with 3 investigators, emphasizing patient‑centered approaches to allergy management.

The dermatology unit at CentroDerm GmbH advances treatments for a range of skin conditions, including moderate‑to‑severe plaque psoriasis, papulopustular acne, actinic keratosis, and moderate to severe platysma prominence. Ongoing studies assess long‑term safety of novel biologics, compare topical gel formulations, and test a potassium hydroxide solution for precancerous lesions.

• Biologic therapy safety profiling
• Comparative efficacy of topical gels
• Non‑invasive imaging of lesion response
• Chemical field treatment for actinic keratosis
• Minimally invasive procedures for facial prominence

With a portfolio of 7 trials, the clinic demonstrates a robust commitment to improving outcomes for patients with chronic skin diseases.

CentroDerm GmbH operates as a non‑commercial hospital‑clinic in Wuppertal, delivering a diverse portfolio of dermatology trials that span immune‑mediated and structural skin disorders. The research program integrates innovative therapies, safety monitoring, and patient‑focused endpoints to enhance diagnostic and treatment standards.

• Multi‑center collaboration across Europe
• Integration of novel diagnostic imaging
• Evaluation of both systemic and topical agents
• Long‑term safety and efficacy assessments
• Alignment with regulatory and ethical guidelines

The site’s 7 clinical investigations, led by 3 investigators, reflect a strong emphasis on advancing dermatologic care without commercial sponsorship.